Saturday, 21 March 2009

Penrazole




Penrazole may be available in the countries listed below.


Ingredient matches for Penrazole



Omeprazole

Omeprazole is reported as an ingredient of Penrazole in the following countries:


  • Singapore

International Drug Name Search

Saturday, 14 March 2009

optive


Generic Name: ocular lubricant (OK yoo lar LOO bri kant)

Brand Names: Artificial Tears, Celluvisc, Clear Eyes CLR, Comfort Tears, Dry Eye Relief, GenTeal, Isopto Tears, Lacri-Lube S.O.P., Lacrisert, Lubricant Eye Drops, Moisture Drops, Oasis Tears, Opti-Free Rewetting Drops, optive, Refresh, Soothe, Sterilube, Systane, Systane Balance, Tears Again, Tears Naturale, Tears Renew, TheraTears, Ultra Fresh, Visine Tears


What is optive (ocular lubricant)?

There are many brands and forms of ocular lubricant available and not all are listed on this leaflet.


Ocular lubricant is a solution specially formulated to moisten the eyes.


Ocular lubricant is used to relieve burning, irritation, and discomfort caused by dry eyes.

Ocular lubricant may also be used for purposes not listed in this medication guide.


What is the most important information I should know about optive (ocular lubricant)?


There are many brands and forms of ocular lubricant available and not all are listed on this leaflet.


You should not use an ocular lubricant if you are allergic to it. Ocular lubricant will not treat or prevent an eye infection.

Ask a doctor or pharmacist if it is safe for you to use this medicine if you have any type of infection in your eye.


Do not allow the dropper or tube tip to touch any surface, including the eyes or hands. If the dropper or tube becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.


Stop using ocular lubricant and call your doctor if you have severe burning, stinging, irritation, eye pain, or vision changes.

This medication may cause blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.


Talk with your doctor if your symptoms do not improve or if they get worse while you are using ocular lubricant.

What should I discuss with my healthcare provider before using optive (ocular lubricant)?


You should not use an ocular lubricant if you are allergic to it. Ocular lubricant will not treat or prevent an eye infection.

Ask a doctor or pharmacist if it is safe for you to use this medicine if you have any type of infection in your eye.


Ocular lubricant is not expected to harm an unborn baby. Ask a doctor or pharmacist about using ocular lubricant if you are pregnant. It is not known whether ocular lubricant passes into breast milk or if it could harm a nursing baby. Ask a doctor or pharmacist about using ocular lubricant if you are pregnant.

How should I use optive (ocular lubricant)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Do not use this medication while wearing contact lenses. Eye medication may contain a preservative that can discolor soft contact lenses. Wait at least 15 minutes after using this medication before putting your contact lenses in. Wash your hands before using ocular lubricant.

To apply the eye drops:



  • Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.




  • Use only the number of drops your doctor has prescribed.




  • Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct. If you use more than one drop in the same eye, wait about 5 minutes before putting in the next drop.




  • Do not use the eye drops if the liquid has changed colors or has particles in it.



To apply the ointment:



  • Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the ointment tube with the tip pointing toward this pocket. Look up and away from the tip.




  • Squeeze out a ribbon of ointment 1/2-inch long into the lower eyelid pocket without touching the tip of the tube to your eye. Look down and close your eyes for a few minutes. Rolling your eyes around gently will help spread the ointment evenly.




  • After opening your eyes, you may have blurred vision for a short time. Avoid driving or doing anything that requires you to be able to see clearly.



Do not allow the dropper or tube tip to touch any surface, including the eyes or hands. If the dropper or tube becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.


Talk with your doctor if your symptoms do not improve or if they get worse while you are using ocular lubricant. Store at room temperature away from moisture and heat. Do not freeze. Keep the bottle or tube tightly closed when not in use.

What happens if I miss a dose?


Since ocular lubricant is used on an as needed basis, you are not likely to miss a dose.


What happens if I overdose?


An overdose of ocular lubricant is not expected to be dangerous.


What should I avoid while using optive (ocular lubricant)?


This medication may cause blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.


Avoid using other medications in your eyes during treatment with ocular lubricant unless your doctor tells you to.


optive (ocular lubricant) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using ocular lubricant and call your doctor if you have a serious side effect such as:

  • severe burning, stinging, or eye irritation after using the medication;




  • eye pain; or




  • vision changes.



Less serious side effects may include:



  • mild eye burning or irritation;




  • itching or redness of your eyes;




  • watery eyes;




  • blurred vision; or




  • unpleasant taste in your mouth.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect optive (ocular lubricant)?


It is not likely that other drugs you take orally or inject will have an effect on ocular lubricant used in the eyes. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More optive resources


  • Optive Use in Pregnancy & Breastfeeding
  • Optive Support Group
  • 0 Reviews for Optive - Add your own review/rating


  • FreshKote Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Genteal Advanced Consumer (Micromedex) - Includes Dosage Information

  • Lacri-Lube S.O.P. Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lacrisert Prescribing Information (FDA)

  • Lacrisert Insert MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lacrisert Advanced Consumer (Micromedex) - Includes Dosage Information

  • Murine Tears Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Murocel Eye Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Refresh Redness Relief Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Refresh liquigel



Compare optive with other medications


  • Eye Dryness/Redness


Where can I get more information?


  • Your pharmacist can provide more information about ocular lubricant.


Monday, 9 March 2009

Tiocolchicoside Union Health




Tiocolchicoside Union Health may be available in the countries listed below.


Ingredient matches for Tiocolchicoside Union Health



Thiocolchicoside

Thiocolchicoside is reported as an ingredient of Tiocolchicoside Union Health in the following countries:


  • Italy

International Drug Name Search

Sunday, 8 March 2009

Bactroban


Bactroban is a brand name of mupirocin topical, approved by the FDA in the following formulation(s):


BACTROBAN (mupirocin - ointment; topical)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: December 31, 1987

    Strength(s): 2% [RLD][AB]

BACTROBAN (mupirocin calcium - cream; topical)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: December 11, 1997

    Strength(s): EQ 2% BASE [RLD]

BACTROBAN (mupirocin calcium - ointment; nasal)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: September 18, 1995

    Strength(s): EQ 2% BASE [RLD]

Has a generic version of Bactroban been approved?


A generic version of Bactroban has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Bactroban and have been approved by the FDA:


mupirocin ointment; topical



  • Manufacturer: FOUGERA PHARMS

    Approval date: November 30, 2005

    Strength(s): 2% [AB]


  • Manufacturer: GLENMARK PHARMS

    Approval date: June 8, 2011

    Strength(s): 2% [AB]


  • Manufacturer: PERRIGO NEW YORK

    Approval date: November 7, 2003

    Strength(s): 2% [AB]


  • Manufacturer: TARO

    Approval date: September 23, 2005

    Strength(s): 2% [AB]


  • Manufacturer: TEVA

    Approval date: November 7, 2003

    Strength(s): 2% [AB]

Note: No generic formulation of the following products are available.


  • mupirocin calcium - cream; topical

  • mupirocin calcium - ointment; nasal

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Bactroban. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pharmaceutical and veterinary compositions of mupirocin and methods for their preparation
    Patent 6,025,389
    Issued: February 15, 2000
    Inventor(s): Zimmerman; Harvey Lee
    Assignee(s): SmithKline Beecham Corporation
    The invention is directed to a pharmaceutical composition comprising a cream base which comprises mupiricin dihydrate, a mineral oil, one or more fatty alcohols or fatty esters, a polyoxyethylene ether or ester surfactant, xanthan gum, water and a method for treating a bacterial infection using said composition.
    Patent expiration dates:

    • October 20, 2014
      ✓ 
      Patent use: TREATMENT OF SECONDARILY INFECTED TRAUMATIC SKIN LESIONS DUE TO S. AUREUS AND S. PYOGENES
      ✓ 
      Drug product



See also...

  • Bactroban Consumer Information (Drugs.com)
  • Bactroban Cream Consumer Information (Wolters Kluwer)
  • Bactroban Ointment Consumer Information (Wolters Kluwer)
  • Bactroban Consumer Information (Cerner Multum)
  • Bactroban Nasal Advanced Consumer Information (Micromedex)
  • Bactroban Topical Advanced Consumer Information (Micromedex)
  • Mupirocin Cream Consumer Information (Wolters Kluwer)
  • Mupirocin Ointment Consumer Information (Wolters Kluwer)
  • Mupirocin nasal Consumer Information (Cerner Multum)
  • Mupirocin topical Consumer Information (Cerner Multum)
  • Mupirocin Nasal Advanced Consumer Information (Micromedex)
  • Mupirocin Topical Advanced Consumer Information (Micromedex)
  • Mupirocin AHFS DI Monographs (ASHP)

Wormstop




Wormstop may be available in the countries listed below.


Ingredient matches for Wormstop



Mebendazole

Mebendazole is reported as an ingredient of Wormstop in the following countries:


  • South Africa

International Drug Name Search

Friday, 6 March 2009

Burana-Caps




Burana-Caps may be available in the countries listed below.


Ingredient matches for Burana-Caps



Ibuprofen

Ibuprofen is reported as an ingredient of Burana-Caps in the following countries:


  • Finland

International Drug Name Search

Wednesday, 4 March 2009

Xalatan


Xalatan is a brand name of latanoprost ophthalmic, approved by the FDA in the following formulation(s):


XALATAN (latanoprost - solution/drops; ophthalmic)



  • Manufacturer: PHARMACIA AND UPJOHN

    Approval date: June 5, 1996

    Strength(s): 0.005% [RLD][AT]

Has a generic version of Xalatan been approved?


Yes. The following products are equivalent to Xalatan:


latanoprost solution/drops; ophthalmic



  • Manufacturer: ALCON RES

    Approval date: March 22, 2011

    Strength(s): 0.005% [AT]


  • Manufacturer: APOTEX

    Approval date: March 22, 2011

    Strength(s): 0.005% [AT]


  • Manufacturer: BAUSCH AND LOMB

    Approval date: March 22, 2011

    Strength(s): 0.005% [AT]


  • Manufacturer: LUITPOLD

    Approval date: March 22, 2011

    Strength(s): 0.005% [AT]


  • Manufacturer: MYLAN

    Approval date: March 22, 2011

    Strength(s): 0.005% [AT]


  • Manufacturer: PADDOCK LLC

    Approval date: July 19, 2011

    Strength(s): 0.005% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xalatan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Xalatan.

See also...

  • Xalatan Consumer Information (Drugs.com)
  • Xalatan Drops Consumer Information (Wolters Kluwer)
  • Xalatan Consumer Information (Cerner Multum)
  • Xalatan Multi-Pack Consumer Information (Cerner Multum)
  • Xalatan Advanced Consumer Information (Micromedex)
  • Xalatan AHFS DI Monographs (ASHP)
  • Latanoprost Drops Consumer Information (Wolters Kluwer)
  • Latanoprost ophthalmic Consumer Information (Cerner Multum)
  • Latanoprost Ophthalmic Advanced Consumer Information (Micromedex)
  • Latanoprost AHFS DI Monographs (ASHP)